Skip to main content

Table 6 IGFBP3 variables and their correlations with gain in height outcomes

From: Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain

ITT

Pubertal gain in heightSDS

Total gain in heightSDS

Prepubertal gain in heightSDS

IGFBP3SDS

n

r

p

r

p

r

p

At GH start

71

−0.05

 

−0.36

0.002

−0.43

0.001

1st year after GH start

76

0.09

 

−0.22

0.052

−0.39

0.001

∆IGFBP3SDS1st year after GH start

63

0.13

 

0.29

0.022

0.24

0.057

Last pre-pubertal

90

−0.14

 

−0.05

 

0.07

 

IGFBP3SDSPrepubertal level

100

−0.12

 

−0.11

 

0.00

 

Study start

104

−0.09

 

−0.03

 

0.06

 

1st year after study start

100

0.09

 

−0.02

   

∆IGFBP3SDS1st year after study start

100

0.20

0.044

0.04

   

Pubertal level

104

0.13

 

0.01

   

∆IGFBP3SDSPubertal level from study start

104

0.30

0.002

0.05

   

Before study stop

104

0.32

0.001

−0.09

   

After study stop

64

0.35

0.005

−0.17

   
  1. Δ change, IGFBP3 IGF-binding protein 3, SDS standard deviation score